Variant form of urate oxidase and use thereof

Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Oxidoreductase

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S252300, C435S320100, C536S023200

Reexamination Certificate

active

07964381

ABSTRACT:
The present invention relates to genetically modified proteins with uricolytic activity. More specifically, the invention relates to proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidases.

REFERENCES:
patent: 3451996 (1969-06-01), Sumyk et al.
patent: 3616231 (1971-10-01), Bergmeyer et al.
patent: 3931399 (1976-01-01), Bohn et al.
patent: 4141973 (1979-02-01), Balazs
patent: 4169764 (1979-10-01), Takezawa et al.
patent: 4179337 (1979-12-01), Davis et al.
patent: 4297344 (1981-10-01), Schwinn et al.
patent: 4301153 (1981-11-01), Rosenberg
patent: 4312979 (1982-01-01), Takemoto et al.
patent: 4317878 (1982-03-01), Nakanishi et al.
patent: 4421650 (1983-12-01), Nagasawa et al.
patent: 4425431 (1984-01-01), Takemoto et al.
patent: 4460575 (1984-07-01), d'Hinterland et al.
patent: 4460683 (1984-07-01), Gloger et al.
patent: 4485176 (1984-11-01), Bollin, Jr. et al.
patent: 4753796 (1988-06-01), Moreno et al.
patent: 4766106 (1988-08-01), Katre et al.
patent: 4797474 (1989-01-01), Patroni et al.
patent: 4847325 (1989-07-01), Shadle et al.
patent: 4917888 (1990-04-01), Katre et al.
patent: 4945086 (1990-07-01), Benitz et al.
patent: 4966963 (1990-10-01), Patroni
patent: 4987076 (1991-01-01), Takashio et al.
patent: 4992531 (1991-02-01), Patroni et al.
patent: 5008377 (1991-04-01), Patroni et al.
patent: 5010183 (1991-04-01), Macfarlane
patent: 5283317 (1994-02-01), Saifer et al.
patent: 5286637 (1994-02-01), Veronese et al.
patent: 5362641 (1994-11-01), Fuks et al.
patent: 5382518 (1995-01-01), Caput et al.
patent: 5428128 (1995-06-01), Mensi-Fattohi et al.
patent: 5458135 (1995-10-01), Patton et al.
patent: 5468478 (1995-11-01), Saifer et al.
patent: 5529915 (1996-06-01), Phillips et al.
patent: 5541098 (1996-07-01), Caput et al.
patent: 5567422 (1996-10-01), Greenwald
patent: 5612460 (1997-03-01), Zalipsky et al.
patent: 5633227 (1997-05-01), Muller et al.
patent: 5637749 (1997-06-01), Greenwald et al.
patent: 5643575 (1997-07-01), Martinez et al.
patent: 5653974 (1997-08-01), Hung et al.
patent: 5766897 (1998-06-01), Braxton
patent: 5811096 (1998-09-01), Aleman et al.
patent: 5880255 (1999-03-01), Delgado et al.
patent: 5919455 (1999-07-01), Greenwald et al.
patent: 5929231 (1999-07-01), Malkki et al.
patent: 5932462 (1999-08-01), Harris et al.
patent: 5948668 (1999-09-01), Hartman et al.
patent: 5955336 (1999-09-01), Shigyo et al.
patent: 6201110 (2001-03-01), Olsen et al.
patent: 6468210 (2002-10-01), Iliff
patent: 6475143 (2002-11-01), Iliff
patent: 6524241 (2003-02-01), Iliff
patent: 6527713 (2003-03-01), Iliff
patent: 6569093 (2003-05-01), Iliff
patent: 6576235 (2003-06-01), Williams et al.
patent: 6608892 (2003-08-01), Shaffer et al.
patent: 6783965 (2004-08-01), Sherman et al.
patent: 6913915 (2005-07-01), Ensor et al.
patent: 2002/0010319 (2002-01-01), Ansaldi et al.
patent: 2003/0082786 (2003-05-01), Ensor et al.
patent: 2003/0166249 (2003-09-01), Williams et al.
patent: 2005/0014240 (2005-01-01), Sherman et al.
patent: 2007/0274977 (2007-11-01), Hartman et al.
patent: 2008/0159976 (2008-07-01), Hartman et al.
patent: 2009/0169534 (2009-07-01), Hartman et al.
patent: 2009/0317889 (2009-12-01), Fischer et al.
patent: 279 486 (1990-06-01), None
patent: 0055188 (1982-06-01), None
patent: 0408 461 (1991-01-01), None
patent: 1 100 542 (2001-05-01), None
patent: 55-99189 (1980-07-01), None
patent: 62-55079 (1987-03-01), None
patent: 03-148298 (1991-06-01), None
patent: 09-154581 (1997-06-01), None
patent: 333148 (1994-09-01), None
patent: 365606 (1998-03-01), None
patent: 369838 (2003-09-01), None
patent: 488848 (2005-05-01), None
patent: 318706 (2007-04-01), None
patent: WO8604145 (1986-07-01), None
patent: WO 94/19007 (1994-09-01), None
patent: WO94/23735 (1994-10-01), None
patent: WO9511987 (1995-05-01), None
patent: WO96/23064 (1996-08-01), None
patent: WO 98/31383 (1998-07-01), None
patent: WO 00/07629 (2000-02-01), None
patent: WO 00/08196 (2000-02-01), None
patent: WO 01/59078 (2001-08-01), None
patent: WO03045436 (2003-06-01), None
Baraf, H.S.B. et al, “Arthritis & Rheumatism” in The Official Journal of the American College of Rheumatology Abstract Supplement, vol. 52, No. 9, p. S105 (Abstract 194) previously submitted as Lee et al., (Sep. 2005) as “Arthritis & Rheumatism” In The Official Journal of the American College of Rheumatology Abstract Supplement, vol. 52, No. 9, p. S105.
European Examination Report for related European Application No. 01 923 265.1 Mailed Dec. 13, 2007, European Patent Office, Munich, DE.
U.S. Publ. Appl. No. US 2005/0014240, Sherman et al., related U.S. Appl. No. 09/639,946, filed Apr. 19, 2001.
Office Action mailed on Sep. 11, 2003; in related U.S. Appl. No. 09/839,946, Williams et al., filed Apr. 19, 2001.
Office Action mailed on Mar. 5, 2004; in related U.S. Appl. No. 09/839,946, Williams et al., filed Apr. 19, 2001.
Office Action mailed on Aug. 2, 2004; in related U.S. Appl. No. 09/839,946, Williams et al.., filed Apr. 19, 2001.
Office Action mailed on Jan. 26, 2005; in related U.S. Appl. No. 09/839,946, Williams et al., filed Apr. 19, 2001.
Office Action mailed on Jul. 20, 2005; in related U.S. Appl. No. 09/839,946, Williams et al., filed Apr. 19, 2001.
Advisory Action mailed on Dec. 5, 2003; in related U.S. Appl. No. 09/839,946, Williams et al., filed Apr. 19, 2001.
Examiner's Answer to Appeal Brief mailed on Jul. 11, 2006; related U.S. Appl. No. 09/839,946, Williams et al., filed Apr. 19, 2001.
BPAI Decision decided on Jul. 18, 2007; in related U.S. Appl. No. 09/839,946, Williams et al., filed Apr. 19, 2001.
Saifer et al., Adv. Exp. Med. Biol., 1994, 366:377-387.
Serafini Fracassini et al., 1967, Biochem. J. 105.569.575.
Ph.-Herve Hirel et al.; “Extent of N-terminal Methionine Excision fromEscherichia coliProteins is Governed by the Side-Chain Length of the Pnultimate Amino Acid,” Proc. Natl. Acad. Sci. USA; vol. 86, pp. 8247-8251, Nov. 1989, Biochemistry.
Sundy, J.S. et al., A Phase I Study of Pegylated-Uricase (Puricase®) in Subjects with Gout, Arthritis Rheum. 2004 vol. 50, supplement 9, S337-338.
Sundy, J.S. et al., A Phase I Study of Pegylated-Uricase (Puricasel®) in Subjects with Gout, presented at American College of Rheumatology Annual Scientific Meeting on Oct. 16-21, 2004 at San Antonio, TX, Poster 807.
Ganson, N.J. et al., Antibodies to Polyethylene Glycol (PEG) during Phase I Investigation of PEG-Urate Oxidase (PEG-uricase; Puricase®) for Refractory Gout, Arthritis Rheum. 2004 vol. 50, supplement 9, S338.
Ganson, N.J. et al., Antibodies to Polyethylene Glycol (PEG) during Phase I Investigation of PEG-Urale Oxidase (PEG-uricase; Puricase®) for Refractory Gout, presented at American College of Rheumatology Annual Scientific Meeting on Oct. 16-21, 2004 at San Antonio, TX, Poster 808.
Baraf H. et al., Resolution of Tophi with Intravenous Peg-uricase in Refractory Gout, Arthritis & Rheumatism, 2005, Sep Supplement, vol. 52, No. 9, p. S105.
Baraf H et al., Resolution of Tophi with Intravenous Peg-uricase in Refractory Gout, presented at American College of Rheumatology 2005 Annual Scientific Meeting on Nov. 13-17, 2005 at San Diego, CA, Poster 194.
Sundy, J.S. et al., A Phase 2 Study of Multiple Doses of Intravenous Polyethylene Glycol (PEG)-uricase in Patients with Hyperuricemia and Refractory Gout, presented at American College of Rheumatology 2005 Annual Scientific Meeting on Nov. 13-17, 2005 at San Diego, CA #1836.
Kelly, S. J., M. Deinomdedieu, et al. (2001) as “Diabetes insipidus in uricase-deficient mice: A model for evaluating therapy with poly(ethylene glycol)-modified uricase.” in J Am Soc Nephrol 12. 1001-1009.
Lee et al., (Sep. 2005) as “Arthritis & Rheumatism” in The Official Journal of the American College of Rheumatology, Abstract Supplement, vol. 52, No. 9, p. S105.
Office Action dated Oct. 30, 2009, U.S. Appl. No. 11/539,475, filed Oct. 6, 2006, Inventor Jacob Hartman.
Office Action dated Jun. 25, 2009, U.S. Appl. No. 11

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Variant form of urate oxidase and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Variant form of urate oxidase and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Variant form of urate oxidase and use thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2641573

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.